Rigel Pharmaceuticals (RIGL)
Commercializes specialty treatments for a blood disorder, a leukemia, and RET-fusion cancers in the US.
$48.14
After hours−0.66 (−1.36%)
At close$48.81(+3.64%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 88.54% | 16.54M shares | |
|---|---|---|---|
| 161 holders · as of Jun 30, 2026 | |||
| Insiders | 3.30% | 615.6K shares | |
| 12 holders · as of Sep 3, 2026 | |||
| Other | 8.16% | 1.53M shares | |
| remainder | |||
18.68M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
13F, as of Jun 30, 2026
161 holders · 16.54M shares · 34 new positions · 88 increased · 55 reduced · 26 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 1.94M | 10.38% | +170.9K | Aug 7, 2026 |
| Soleus Capital Management, L.P. | 1.84M | 9.87% | +1.83M | Aug 11, 2026 |
| Armistice Capital, LLC | 1.67M | 8.95% | +392.0K | Aug 14, 2026 |
| State Street Corp | 1.04M | 5.57% | −80.2K | Aug 7, 2026 |
| Vanguard Capital Management LLC | 785.1K | 4.20% | +20.9K | Aug 13, 2026 |
| American Century Companies Inc | 741.7K | 3.97% | +197.3K | Aug 12, 2026 |
| LSV Asset Management | 721.7K | 3.86% | +120.2K | Aug 6, 2026 |
| Acadian Asset Management LLC | 591.7K | 3.17% | −74.7K | Aug 13, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 7.70% | 1.38M | 13G | Apr 17, 2025 |
| Armistice Capital, LLC | 6.93% | 1.28M | 13G | May 15, 2026 |
| State Street Corporation | 6.00% | 1.09M | 13G | Feb 9, 2026 |
| Soleus Capital Master Fund, L.P. | 5.20% | 968.1K | 13G | May 7, 2026 |
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Jun 22, 2026 | Kamil Ali-Jacksondirector | Sale | 2,500 | $35.00 | 10,125 |
| May 26, 2026 | Kamil Ali-Jacksondirector | Sale | 2,500 | $29.17 | 12,625 |
| Feb 20, 2026 | Walter H. Moosdirector | Sale | 4,000 | $36.36 | 12,722 |
House and Senate disclosures
Not reported.